This inventor holds 1 USPTO granted patent. Top assignee: Forschungszentrum Karlsruhe Gmbh. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Carsten Weiss: Innovator in Tumor Treatment and Immunosuppression
Introduction
Carsten Weiss is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of tumor diseases and immunosuppression. His innovative approach has led to the development of a unique method that holds promise for future therapies.
Latest Patents
Carsten Weiss holds a patent for a "Method for producing agents for treating tumor diseases and for immunosuppression." This invention involves a process for preparing agents that are suitable for treating tumor diseases or for immunosuppression. The method includes treating target cells with chemical compounds that bind to the Ah receptor of the target cells. The binding of these compounds is determined by measuring the expression of a detector gene that is relevant for the effects of the chemical compounds. The compounds identified through this process are then utilized for preparing the therapeutic agents. He has 1 patent to his name.
Career Highlights
Carsten Weiss is associated with Forschungszentrum Karlsruhe GmbH, where he has been involved in groundbreaking research. His work focuses on developing innovative solutions for complex medical challenges. His dedication to advancing medical science is evident in his research and patent contributions.
Collaborations
Throughout his career, Carsten Weiss has collaborated with esteemed colleagues, including Martin Göttlicher and Siva Kumar Kolluri. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their field.
Conclusion
Carsten Weiss is a distinguished inventor whose work in tumor treatment and immunosuppression showcases the potential of innovative medical solutions. His contributions are paving the way for advancements in therapeutic agents that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile